Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22350
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBracken, Karen-
dc.contributor.authorHague, Wendy-
dc.contributor.authorKeech, Anthony-
dc.contributor.authorConway, Ann-
dc.contributor.authorHandelsman, David J-
dc.contributor.authorGrossmann, Mathis-
dc.contributor.authorJesudason, David-
dc.contributor.authorStuckey, Bronwyn-
dc.contributor.authorYeap, Bu B-
dc.contributor.authorInder, Warrick-
dc.contributor.authorAllan, Carolyn-
dc.contributor.authorMcLachlan, Robert-
dc.contributor.authorRobledo, Kristy P-
dc.contributor.authorWittert, Gary-
dc.date2019-06-12-
dc.date.accessioned2020-01-07T00:33:34Z-
dc.date.available2020-01-07T00:33:34Z-
dc.date.issued2019-06-19-
dc.identifier.citationTrials 2019; 20(1): 366en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/22350-
dc.description.abstractEffective interventions are required to prevent the current rapid increase in the prevalence of Type 2 diabetes. Clinical trials of large-scale interventions to prevent Type 2 diabetes are essential but recruitment is challenging and expensive, and there are limited data regarding the most cost-effective and efficient approaches to recruitment. This paper aims to evaluate the cost and effectiveness of a range of promotional strategies used to recruit men to a large Type 2 diabetes prevention trial. An observational study was conducted nested within the Testosterone for the Prevention of Type 2 Diabetes (T4DM) study, a large, multi-centre randomised controlled trial (RCT) of testosterone treatment for the prevention of Type 2 diabetes in men aged 50-74 years at high risk of developing diabetes. Study participation was promoted via mainstream media-television, newspaper and radio; direct marketing using mass mail-outs, publicly displayed posters and attendance at local events; digital platforms, including Facebook and Google; and online promotions by community organisations and businesses. For each strategy, the resulting number of participants and the direct cost involved were recorded. The staff effort required for each strategy was estimated based on feedback from staff. Of 19,022 men screened for the study, 1007 (5%) were enrolled. The most effective recruitment strategies were targeted radio advertising (accounting for 42% of participants), television news coverage (20%) and mass mail-outs (17%). Other strategies, including radio news, publicly displayed posters, attendance at local events, newspaper advertising, online promotions and Google and Facebook advertising, each accounted for no more than 4% of enrolled participants. Recruitment promotions cost an average of AU$594 per randomised participant. The most cost-effective paid strategy was mass mail-outs by a government health agency (AU$745 per participant). Other paid strategies were more expensive: mail-out by general practitioners (GPs) (AU$1104 per participant), radio advertising (AU$1081) and newspaper advertising (AU$1941). Radio advertising, television news coverage and mass mail-outs by a government health agency were the most effective recruitment strategies. Close monitoring of recruitment outcomes and ongoing enhancement of recruitment activities played a central role in recruitment to this RCT. ANZCTR, ID: ACTRN12612000287831 . Registered on 12 March 2012.en_US
dc.language.isoeng-
dc.subjectAdvertisingen_US
dc.subjectDiabetes preventionen_US
dc.subjectMen’s healthen_US
dc.subjectParticipant recruitmenten_US
dc.subjectRandomised controlled trialsen_US
dc.subjectRecruitment strategiesen_US
dc.subjectSocial mediaen_US
dc.titleRecruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleTrialsen_US
dc.identifier.affiliationAnzac Research Institute, and Andrology Department, Concord Hospital, Sydney, NSW, Australiaen_US
dc.identifier.affiliationDepartment of Endocrinology and Diabetes, Keogh Institute of Medical Research, Sir Charles Gairdner Hospital and Medical School, University of Western Australia, Perth, WA, Australiaen_US
dc.identifier.affiliationQueen Elizabeth Hospital, Adelaide, SA, Australiaen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.affiliationFreemasons Foundation Centre for Men's Health, School of Medicine, University of Adelaide, Adelaide, SA, Australiaen_US
dc.identifier.affiliationNHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australiaen_US
dc.identifier.affiliationDepartment of Clinical Research, Hudson Institute of Medical Research, Melbourne, VIC, Australiaen_US
dc.identifier.affiliationPrincess Alexandra Hospital, Brisbane, QLD, Australiaen_US
dc.identifier.affiliationDepartment of Endocrinology and Diabetes, Medical School, University of Western Australia and Fiona Stanley Hospital, Perth, WA, Australiaen_US
dc.identifier.affiliationEndocrinologyen_US
dc.identifier.doi10.1186/s13063-019-3485-2en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-6085-445Xen_US
dc.identifier.orcid0000-0001-8261-3457en_US
dc.identifier.pubmedid31217024-
dc.type.austinClinical Trial, Phase III-
dc.type.austinJournal Article-
dc.type.austinMulticenter Study-
dc.type.austinObservational Study-
dc.type.austinRandomized Controlled Trial-
local.name.researcherGrossmann, Mathis
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

26
checked on Jan 15, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.